Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence

So this was sent to me by a lovely GP friend of mine *waves hello*! and was a systematic literature review and meta-analysis of published and unpublished double-blind randomized controlled trials with regard to nalmefene, a new drug that was rubber stamped by NICE within the last few years for treatment of moderate adult alcohol … Continue reading Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence

Local Nalmefene pathways emerging to ensure prescribing adherence

This excellent post came from Alcohol Policy UK in October regarding Nalmefene (Trade name Selincro) and pathways to prescribing. Following NICE’s technical appraisal authorising Nalmefene (Selincro) last year, local areas have been developing protocols to ensure prescribing adherence – see below for examples. Nalmefene was authorised as a drug to support a reduced drinking goal … Continue reading Local Nalmefene pathways emerging to ensure prescribing adherence

Statistics on Alcohol England 2017

An excellent blog post as always from Alcohol Policy UK in May looking at the latest statistics on Alcohol England for 2017 & Opinions and Lifestyle Survey (OPN) drinking figures. Over to James: The annual Statistics on Alcohol for England 2017 has been released, detailing national data for key alcohol-related indicators and health harms. Mainly … Continue reading Statistics on Alcohol England 2017

Alcohol dependence: insights into prevalence, children & intention to change

Another brilliant blog post from Alcohol Policy UK looking at new research published about alcohol dependence, prevalence, impact on children and expressed desire to change.  Over to James: New research has been released assessing the prevalence of alcohol dependence in England, including the first estimates of dependence by local area. The analysis also explores the … Continue reading Alcohol dependence: insights into prevalence, children & intention to change

Alcoholics Anonymous saved my life, but now I’ve lost my faith

This was in The Guardian in November and is an interview with Jon Stewart from Sleeper (second from left). My first day of sobriety was the first day I prayed. I’d always been a staunch atheist; I grew up in Yorkshire during the miners’ strike, and was raised on left-wing politics. When I went to … Continue reading Alcoholics Anonymous saved my life, but now I’ve lost my faith

High-dose baclofen for the treatment of alcohol dependence

This study was featured on Findings from earlier this year: High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial. From Germany the first trial to rigorously test high doses of the muscle relaxant baclofen for the treatment of dependent drinking found post-detoxification drinking reductions of a magnitude rarely seen; safety … Continue reading High-dose baclofen for the treatment of alcohol dependence

Shocking level of anti-booze drug prescriptions revealed as recommended limits set to be cut

This was covered in the Manchester Evening News in July.  I’m not sure I’d consider the level of alcohol dependence drug prescriptions prescribed shocking but then how else do you sell newspapers if your headlines aren’t dramatic? More than 25,000 prescriptions were written in Greater Manchester last year for drugs to help people combat alcohol … Continue reading Shocking level of anti-booze drug prescriptions revealed as recommended limits set to be cut

Alcohol and Hypertension

A new factsheet from Alcohol Concern, released on Monday 18 May, looks at the increasing risk alcohol has on hypertension. Hypertension, a form of continued high blood pressure, is a condition experienced by more than one in four adults in the England, with alcohol being a major contributory factor in its development. Regularly drinking alcohol … Continue reading Alcohol and Hypertension

Calling time on missed opportunities: commissioning alcohol services to reduce avoidable harm

This was an interesting supplement that was covered by Guidelines in Practice a best practice online resource and was titled: Calling time on missed opportunities: commissioning alcohol services to reduce avoidable harm.  It carried a big old disclaimer before you even read the piece outlining Lundbeck’s, the pharmaceutical company responsible for Selincro (nalmefene) the new … Continue reading Calling time on missed opportunities: commissioning alcohol services to reduce avoidable harm

A comprehensive list of alcohol’s harms and benefits in a cost-benefit diagram

The now defunct Government Cabinet Office Strategy Unit once attempted to capture a comprehensive list of alcohol’s harms and benefits in a cost-benefit diagram Here it is (click to enlarge) What I find interesting is that there are 17 above the line costs and only 5 below the line benefits.  Feels like a lot of … Continue reading A comprehensive list of alcohol’s harms and benefits in a cost-benefit diagram